CD163 and classic Hodgkin lymphoma: Especially when comparing presumably adverse prognostic constellations in cHL (CD83 low or CD163 high) with cHL cases with an expected better prognosis (CD83 high or CD163 low) anti-inflammatory (IL10, TGFβ1) cytokines were significantly upregulated in the adverse group.